Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
[There are more than 4000 known inherited disorders. The majority of them have minimal effects, but a few causes physical and mental abnormalities that may be life threatening. Genetic diseases that are candidates for gene therapies include severe combined immunodeficiency, thalassaemia, and cystic fibrosis, etc. (Fig. 19.1). Since these genetic diseases are each caused by a single defective gene, one potential treatment is to introduce a normal functional copy of the gene into the cell tissue that is affected. In effect, the normal (therapeutic) gene augments the defective gene in the patient. Gene therapy is not restricted to only treating genetic disorders. The general technology of transferring genetic materials into a patient is also applied to diseases such as cancer, AIDS, and cardiovascular diseases. Many of the approved clinical trials on gene therapy are for the treatment of diseases other than genetic disorders (Table 19.1).]
Published: May 27, 2018
Keywords: Approved Clinical Trials; Severe Combined Immunodeficiency; Retroviral Core Proteins; Bovine Leukemia Virus; Adeno-associated Virus
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.